We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Infusion Chemotherapy in Head and Neck Tumors

Arch Surg. 1966;92(6):951-957. doi:10.1001/archsurg.1966.01320240139031.
Text Size: A A A
Published online


THE PATIENTS with advanced cancers of the head and neck remain a difficult palliative problem for the oncologist. Their systemic metastases develop relatively late in spite of the locally extensive disease and often the adjacent tissues will tolerate no additional radiation therapy; and the tumor distribution is such that neurosurgical procedures have little or nothing to offer for pain relief. This study evaluates the role of intraarterial infusion chemotherapy in such advanced head and neck cancer patients in terms of pain relief, tumor regression, and operability after infusion therapy.

Materials and Methods  Eleven patients with advanced head and neck tumors were given 15 courses of intra-arterial infusion chemotherapy. Their ages ranged from 18 to 81 years, their mean age being 49 years. Nine of the patients were male, two were female. Nine patients had squamous cell carcinomas of the head and neck region, one patient had a malignant melanoma of


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.